Concepedia

Beata Mehes

BM

Statistics

Publications

2

Citations

122

H-Index

2

Active since

2022

Affiliations

Novartis (Switzerland)(Current)

Beata Mehes is an author at Novartis (Switzerland) specializing in covid-19.

Top concepts

Publications per year

2022–2024

2

Publications

2

DFV890: a new oral NLRP3 inhibitor—tested in an early phase 2a randomised clinical trial in patients with COVID-19 pneumonia and impaired respiratory function

Ildikó Madurka, Alexander Vishnevsky, Joan B. Soriano et al. · Infection · 2022 · 77 citations · Full text

, , +4

First‐in‐human safety, tolerability, and pharmacokinetic results of DFV890, an oral low‐molecular‐weight NLRP3 inhibitor

Ewa Gatlik, Beata Mehes, Emilie Voltz et al. · Clinical and Translational Science · 2024 · 45 citations · Full text

1–2 of 2